News & Analysis on Clinical Trial Services & Contract Research And Development
Key Biologics and Cascade Regional Blood Services’ multi-year agreement will provide researchers with the critical raw material needed for developing cell- and gene-based therapies.
Though larger pharma companies are investing heavily in biologics, the industry is set to be predominantly focused on small molecules moving forwards, claims CAS MD.
Researchers are making the case for clinical trial completion bonuses – the complete rejection of which they argue is unnecessary and problematic.